Skip to content
healthcare.dev
Get a free key

Dovato

NDC 49702-246, dolutegravir sodium and lamivudine, tablet, film coated, from ViiV Healthcare Company.

Product NDC
49702-246
Status
Listed
Labeler
ViiV Healthcare Company
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA211994
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49702-246 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOLUTEGRAVIR SODIUM50 mg/1
  • LAMIVUDINE300 mg/1

Pharmacologic classes

HIV Integrase Inhibitors [MoA]; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
49702-246-134970202461330 TABLET, FILM COATED in 1 BOTTLE (49702-246-13)
49702-246-33497020246331 BLISTER PACK in 1 CARTON (49702-246-33) / 30 TABLET, FILM COATED in 1 BLISTER PACK
49702-246-62497020246621 BLISTER PACK in 1 CARTON (49702-246-62) / 14 TABLET, FILM COATED in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/68e45422-43ed-4cfb-9356-fae88d14a53a

  • NADAC price for package 49702024613

    GET /v1/drugs/nadac/49702024613

  • NADAC price for package 49702024633

    GET /v1/drugs/nadac/49702024633

Use it

Look up 49702-246 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49702-246 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49702-246. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.